Steady-State Kinetics and Dynamics of Morphine in Cancer Patients: Is Sedation Related to the Absorption Rate of Morphine?
- 30 September 1999
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 18 (3) , 164-173
- https://doi.org/10.1016/s0885-3924(99)00068-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer painJournal of Pain and Symptom Management, 1996
- Plasma Concentrations of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide After Intravenous and Oral Administration to Healthy VolunteersTherapeutic Drug Monitoring, 1995
- Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPain, 1995
- Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant painPain, 1994
- Myoclonic spasms during treatment with high doses of intravenous morphine in renal failureActa Anaesthesiologica Scandinavica, 1993
- Paradoxical painThe Lancet, 1992
- Morphine‐6‐glucuronide and Morphine: popioid Receptor Binding and Effects on Dopamine‐Sensitive Adenylate Cyclase in StriatumBasic & Clinical Pharmacology & Toxicology, 1991
- Morphine‐6‐Glucuronide: Receptor Binding Profile in Bovine Caudate NucleusBasic & Clinical Pharmacology & Toxicology, 1991
- POTENTIAL ANALGESIC CONTRIBUTION FROM MORPHINE-6-GLUCURONIDE IN CSFThe Lancet, 1987
- Steady-State Pharmacokinetics of Controlled Release Oral Morphine Sulphate in Healthy SubjectsClinical Pharmacokinetics, 1986